Evidence map›Paper›PMID 30827058›Full record

ArticleMolecular genetics & genomic medicine2019

Low frequency of POLD1 and POLE exonuclease domain variants in patients with multiple colorectal polyps.

Fadwa A Elsayed, Carli M J Tops, Maartje Nielsen, Dina Ruano, Hans F A Vasen, Hans Morreau, Frederik J Hes, Tom van Wezel

Open access · goldAbstract read
In one paragraph

Article in Molecular genetics & genomic medicine, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.9field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 8 citations in OpenAlex.

  1. Trial
  2. Review
  3. Article
  4. How many is too many? Polyposis syndromes and what to do next.Current opinion in gastroenterology · 2022
    Review
  5. Article
  6. Review
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 2 countries.

Fadwa A ElsayedDepartment of Pathology, LUMC, Leiden, The Netherlands.
Carli M J TopsDepartment of Clinical Genetics, LUMC, Leiden, The Netherlands.
Maartje NielsenDepartment of Clinical Genetics, LUMC, Leiden, The Netherlands.ORCID 0000-0002-5351-1870
Dina RuanoDepartment of Pathology, LUMC, Leiden, The Netherlands.
Hans F A VasenDepartment of Gastroenterology, LUMC, Leiden, The Netherlands.ORCID 0000-0003-2682-2603
Hans MorreauDepartment of Pathology, LUMC, Leiden, The Netherlands.
Frederik J HesDepartment of Clinical Genetics, LUMC, Leiden, The Netherlands.ORCID 0000-0002-3025-0882
Tom van WezelDepartment of Pathology, LUMC, Leiden, The Netherlands.ORCID 0000-0001-5773-7730
Loyola University Medical Center · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundGermline mutations affecting the exonuclease domains of POLE and POLD1 predispose to colorectal adenomas and carcinoma. Here, we aimed to screen the exonuclease domains to find the genetic causes of multiple colorectal polyps in unexplained cases.

methodsUsing a custom next-generation sequencing panel, we sequenced the exonuclease domains of POLE and POLD1 in 332 index patients diagnosed with multiple colorectal polyps without germline alteration in colorectal polyposis predisposing genes.

resultsWe identified two variants of unknown significance. One germline POLD1 c.961G>A, p.(Gly321Ser) variant was found in two cases. The first patient was diagnosed with multiple polyps at age 35 and colorectal cancer (CRC) at age 37, with no known family history of CRC. The second patient was diagnosed with CRC at age 44 and cumulatively developed multiple polyps; this patient had two sisters with endometrial cancer who did not carry the variant. Furthermore, we identified a novel POLD1 c.955 T>G, p.(Cys319Gly) variant in a patient diagnosed with multiple colorectal adenomas at age 40. Co-segregation analysis showed that one sister who cumulatively developed multiple adenomas from age 34, and another sister who developed CRC at age 38 did not carry the variant. We did not identify pathogenic variants in POLE and POLD1.

conclusionThis study confirms the low frequency of causal variants in these genes in the predisposition for multiple colorectal polyps, and also establishes that these genes are a rare cause of the disease.

Indexed as

Mutation RateAdolescentAdultAgedAged, 80 and overCatalytic DomainColonic PolypsColorectal NeoplasmsDNA Polymerase IIDNA Polymerase IIIFemaleGerm-Line MutationHumansMaleMiddle AgedMutation, MissenseDNA Polymerase IIDNA Polymerase IIIPOLD1 protein, humanPOLE protein, humanPoly-ADP-Ribose Binding Proteinscolorectal cancercolorectal polyposisDNA polymeraseexonuclease domaingermline mutationsPOLD1

Identifiers

PMID30827058
PMCPMC6465667
OpenAlexW2920581822

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.